AmerisourceBergen Corp. (NYSE:ABC) insider Lazarus Krikorian sold 20,276 shares of the company’s stock in a transaction dated Wednesday, November 28th. The shares were sold at an average price of $90.37, for a total transaction of $1,832,342.12. Following the completion of the sale, the insider now directly owns 28,419 shares in the company, valued at approximately $2,568,225.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of ABC opened at $88.90 on Friday. The company has a current ratio of 0.93, a quick ratio of 0.50 and a debt-to-equity ratio of 1.48. The company has a market cap of $19.18 billion, a P/E ratio of 13.70, a PEG ratio of 1.35 and a beta of 0.97. AmerisourceBergen Corp. has a 1 year low of $77.28 and a 1 year high of $106.27.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.44 by $0.01. The business had revenue of $43.30 billion for the quarter, compared to the consensus estimate of $43.27 billion. AmerisourceBergen had a net margin of 0.99% and a return on equity of 45.54%. The company’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.33 earnings per share. On average, equities analysts predict that AmerisourceBergen Corp. will post 6.81 EPS for the current year.
Several analysts have issued reports on ABC shares. Zacks Investment Research downgraded shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Wednesday, October 3rd. Mizuho reaffirmed a “neutral” rating on shares of AmerisourceBergen in a report on Wednesday, September 19th. ValuEngine raised shares of AmerisourceBergen from a “sell” rating to a “hold” rating in a report on Wednesday, September 19th. Finally, Royal Bank of Canada set a $90.00 price target on shares of AmerisourceBergen and gave the company a “hold” rating in a report on Wednesday, November 7th. One analyst has rated the stock with a sell rating, seven have given a hold rating and nine have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $100.87.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Migdal Insurance & Financial Holdings Ltd. lifted its stake in shares of AmerisourceBergen by 140.9% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,142 shares of the company’s stock valued at $105,000 after buying an additional 668 shares during the period. First Mercantile Trust Co. purchased a new position in shares of AmerisourceBergen during the second quarter valued at approximately $107,000. Financial Gravity Wealth Inc. lifted its stake in shares of AmerisourceBergen by 93.2% during the third quarter. Financial Gravity Wealth Inc. now owns 1,254 shares of the company’s stock valued at $108,000 after buying an additional 605 shares during the period. Truvestments Capital LLC purchased a new position in shares of AmerisourceBergen during the third quarter valued at approximately $120,000. Finally, Centaurus Financial Inc. purchased a new position in shares of AmerisourceBergen during the second quarter valued at approximately $129,000. 64.73% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “Insider Selling: AmerisourceBergen Corp. (ABC) Insider Sells 20,276 Shares of Stock” was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.com-unik.info/2018/12/02/insider-selling-amerisourcebergen-corp-abc-insider-sells-20276-shares-of-stock.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Recommended Story: Cash Flow
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.